Skip to content

Clinical study on using autologous immunocytes to improve the immune function

Clinical study on using autologous immunocytes to improve the immune function

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OOh-17011878
Enrollment
Unknown
Registered
2017-07-05
Start date
2017-07-20
Completion date
Unknown
Last updated
2017-10-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Volunteers

Interventions

A:20 healthy subjects were enrolled into this study. Leukoapheresis was performed to get target dose of cells. After amplification in vitro, autologous NK cells were intravenously infused into subj

Sponsors

Shanghai Changzheng Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 55 Years

Inclusion criteria

Inclusion criteria: Healthy human subjects, evenly divided between male and female aged 45 to 55 years old

Exclusion criteria

Exclusion criteria: 1. Subjects whose physical examination results cannot meet the requirments of leukoapheresis; 2. Subjects with NK lymphoma; 3. Subjects whose physical examination results cannot meet the requirments of infusion; 4. Subjects with physical allergy or known allergic to ingredients and product (including other drugs).

Design outcomes

Primary

MeasureTime frame
T cell population, transcriptome sequencing of specific subtype of T cells, cytokine production;Clinical evaluation;

Countries

China

Contacts

Public ContactXiaofeng Tang

Shanghai Changzheng Hospital

jack_tangxf@163.com+86-13061788597

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 11, 2026